$XXII
22nd Century Group, Inc. Stock $xxii

$xxii Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000114420414068255 Filed on November 14, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q4
Revenue	$911.00	$64.43K	$7.230M
YoY Change	-99.99%	22.73%
Cost Of Revenue	$0.00	$305.8K	$440.0K
YoY Change	-100.0%	1388.31%	4300.0%
Gross Profit	-$806.00	-$241.4K	$6.780M
YoY Change	-100.01%	-855.61%
Gross Profit Margin	-88.47%	-374.69%	93.78%
Selling, General & Admin	$5.170M	$1.834M	$650.0K
YoY Change	695.38%	101.06%	32.65%
% of Gross Profit			9.59%
Research & Development	$380.0K	$349.3K	$250.0K
YoY Change	52.0%	144.44%	4.17%
% of Gross Profit			3.69%
Depreciation & Amortization	$150.0K	$74.73K	-$30.00K
YoY Change	-600.0%	24.55%	-115.0%
% of Gross Profit			-0.44%
Operating Expenses	$5.720M	$2.583M	$870.0K
YoY Change	557.47%	144.82%	11.54%
Operating Profit	-$5.717M	-$2.825M	$5.910M
YoY Change	-196.74%	159.92%	-857.69%
Interest Expense	$130.0K	$1.788K	-$10.12M
YoY Change	-101.28%	-100.01%	187.5%
% of Operating Profit			-171.24%
Other Income/Expense, Net	$0.00	$100.5K	-$3.610M
YoY Change	-100.0%	-100.7%
Pretax Income	-$5.590M	-$2.720M	-$7.820M
YoY Change	-28.52%	-82.3%	81.44%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$5.590M	-$2.724M	-$7.820M
YoY Change	-28.52%	-82.28%	81.86%
Net Earnings / Revenue	-613623.05%	-4228.26%	-108.16%
Basic Earnings Per Share
Diluted Earnings Per Share	-$87.47K	-$45.26K	-$153.5K
COMMON SHARES
Basic Shares Outstanding	64.33M shares	60.10M shares	49.72M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.400M	$10.02M	$5.830M
YoY Change	9.78%	863.46%
Cash & Equivalents	$6.403M	$10.02M	$5.831M
Short-Term Investments
Other Short-Term Assets	$2.190M	$4.220M	$460.0K
YoY Change	376.09%	21000.0%	4500.0%
Inventory	$2.065M	$1.750M	$1.406M
Prepaid Expenses	$214.5K	$175.0K	$0.00
Receivables	$0.00	$40.00K	$0.00
Other Receivables	$0.00	$0.00	$10.00K
Total Short-Term Assets	$10.71M	$16.04M	$7.744M
YoY Change	38.26%	569.66%	504.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.851M	$2.881M	$2.998M
YoY Change	-4.91%	10848.32%	49614.1%
Goodwill		$852.0K	$0.00
YoY Change
Intangibles	$7.078M	$5.528M	$1.545M
YoY Change	358.15%	289.55%	14.16%
Long-Term Investments	$1.320M	$1.390M	$7.529M
YoY Change	-82.47%
Other Assets		$5.528M	$1.545M
YoY Change
Total Long-Term Assets	$11.25M	$10.65M	$1.545M
YoY Change	628.0%	637.11%	13.8%
TOTAL ASSETS
Total Short-Term Assets	$10.71M	$16.04M	$7.744M
Total Long-Term Assets	$11.25M	$10.65M	$1.545M
Total Assets	$21.95M	$26.69M	$12.29M
YoY Change	78.68%	595.05%	364.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$884.4K	$490.0K	$54.67K
YoY Change	1517.88%	-3.91%	-96.12%
Accrued Expenses	$1.082M	$1.830M	$575.7K
YoY Change	87.86%	1208.88%	14.46%
Deferred Revenue
YoY Change
Short-Term Debt	$170.0K	$170.0K	$170.0K
YoY Change	0.0%	0.0%	-91.79%
Long-Term Debt Due	$320.0K		$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$2.673M	$2.500M	$984.3K
YoY Change	171.6%	13.3%	-78.62%
LONG-TERM LIABILITIES
Long-Term Debt	$610.0K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.460M	$3.220M	$3.780M
YoY Change	-8.47%	-82.73%	-9.35%
Total Long-Term Liabilities	$4.070M	$3.220M	$3.780M
YoY Change	7.67%	-82.73%	-9.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.673M	$2.500M	$984.3K
Total Long-Term Liabilities	$4.070M	$3.220M	$3.780M
Total Liabilities	$6.734M	$6.560M	$4.764M
YoY Change	41.35%	-68.53%	-45.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$55.53M	-$49.93M	-$39.93M
YoY Change	39.06%	55.52%	189.84%
Common Stock	$641.00	$641.00	$569.00
YoY Change	12.65%		65.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.22M	$20.13M	$7.523M
YoY Change
Total Liabilities & Shareholders Equity	$21.95M	$26.69M	$12.29M
YoY Change	78.68%	595.05%	364.55%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q4
OPERATING ACTIVITIES
Net Income	-$5.590M	-$2.724M	-$7.820M
YoY Change	-28.52%	-82.28%	81.86%
Depreciation, Depletion And Amortization	$150.0K	$74.73K	-$30.00K
YoY Change	-600.0%	24.55%	-115.0%
Cash From Operating Activities	-$2.780M	-$1.570M	$6.280M
YoY Change	-144.27%	72.53%	-1465.22%
INVESTING ACTIVITIES
Capital Expenditures	-$270.0K	-$370.0K	-$680.0K
YoY Change	-60.29%	516.67%	325.0%
Acquisitions
YoY Change
Other Investing Activities	-$560.0K	-$1.580M	-$2.970M
YoY Change	-81.14%	15700.0%
Cash From Investing Activities	-$830.0K	-$1.950M	-$3.650M
YoY Change	-77.26%	3150.0%	2181.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	9.350M	2.170M
YoY Change	-100.0%	499.36%	250.0%
NET CHANGE
Cash From Operating Activities	-2.780M	-1.570M	6.280M
Cash From Investing Activities	-830.0K	-1.950M	-3.650M
Cash From Financing Activities	0.000	9.350M	2.170M
Net Change In Cash	-3.610M	5.830M	4.800M
YoY Change	-175.21%	888.14%
FREE CASH FLOW
Cash From Operating Activities	-$2.780M	-$1.570M	$6.280M
Capital Expenditures	-$270.0K	-$370.0K	-$680.0K
Free Cash Flow	-$2.510M	-$1.200M	$6.960M
YoY Change	-136.06%	41.18%	-2420.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2997760	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	569	USD
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	641	USD
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	70060823	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26689999	USD
CY2013Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	42069	USD
CY2013Q4	us-gaap	Due From Officers Or Stockholders Current DueFromOfficersOrStockholdersCurrent	7471	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	1406280	USD
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	0	USD
CY2013Q4	us-gaap	Cash Cash	5830599	USD
CY2013	xxii	Common Stock Warrants Issued Additional Number CommonStockWarrantsIssuedAdditionalNumber	1665400	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2014Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2014Q3	us-gaap	Cash Cash	10020548	USD
CY2014Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	44569	USD
CY2014Q3	us-gaap	Due From Officers Or Stockholders Current DueFromOfficersOrStockholdersCurrent	0	USD
CY2013Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	457696	USD
CY2014Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	175023	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	16035890	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	7744115	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2880613	USD
CY2014Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	47452055	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-49934988	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39929736	USD
CY2014Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20126476	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7522888	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12286744	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt"> Reclassifications</font></i></strong><i><font style="FONT-SIZE: 10pt">-</font></i> <font style="FONT-SIZE: 10pt"> Certain items in the 2013 financial statements have been reclassified to conform to the 2014 classification.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></strong><strong><font style="FONT-SIZE: 10pt">-</font></strong> <font style="FONT-SIZE: 10pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the U.S., requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Licenses Revenue LicensesRevenue	7000000	USD
CY2014Q3	us-gaap	License Costs LicenseCosts	246434	USD
CY2013Q4	us-gaap	Deferred Revenue DeferredRevenue	179014	USD
	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	7000000	USD
CY2014Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64075042	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56902770	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64075042	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56902770	shares
	xxii	Working Capital WorkingCapital	13540817	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10020548	USD
	us-gaap	Liquidity Disclosure Sufficient Cash And Waivers Note LiquidityDisclosureSufficientCashAndWaiversNote	The Company believes it will have adequate cash reserves to sustain operations and meet all current obligations as they come due for a period in excess of 12 months.
CY2014Q2	us-gaap	Capital Required To Be Well Capitalized CapitalRequiredToBeWellCapitalized	45000000	USD
	us-gaap	Description Of Regulatory Requirements Capital Adequacy Purposes DescriptionOfRegulatoryRequirementsCapitalAdequacyPurposes	The universal shelf registration statement will allow, but not compel, the Company to raise up to $45 million of capital over a three-year period through a wide array of securities at times and in amounts to be determined by the Company.
CY2013Q1	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	2500000	USD
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	2035000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	702166	USD
CY2014Q3	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	64431	USD
	us-gaap	Depreciation Depreciation	149011	USD
CY2013Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3220000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	210000	USD
	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	631484	USD
CY2013Q4	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	457696	USD
CY2014Q4	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	88167	USD
CY2014Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3004848	USD
CY2013Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3220000	USD
CY2014Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	34132	USD
CY2013Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	17059	USD
CY2014Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	0	USD
CY2013Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	14500	USD
CY2014Q3	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	0	USD
CY2013Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	210000	USD
CY2014Q3	xxii	Property Plant And Equipment Including Assets Held For Sale PropertyPlantAndEquipmentIncludingAssetsHeldForSale	3038980	USD
CY2013Q4	xxii	Property Plant And Equipment Including Assets Held For Sale PropertyPlantAndEquipmentIncludingAssetsHeldForSale	3461559	USD
CY2014Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3038980	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3003863	USD
CY2014Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	158367	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6103	USD
CY2014Q2	us-gaap	Equity Method Investments EquityMethodInvestments	250000	USD
CY2014Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.1	pure
CY2014Q3	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	325000	USD
CY2013	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0075	pure
	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0075	pure
CY2014Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0400	pure
CY2013Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0400	pure
	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	30 days
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10653469	shares
CY2013Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	3987655	USD
	xxii	Warrant Exchange Inducement Expense WarrantExchangeInducementExpense	144548	USD
	xxii	Warrants Without Provision Of Anti Dilution WarrantsWithoutProvisionOfAntiDilution	13544600	shares
CY2014Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	142858	USD
CY2013Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	3921381	USD
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	9154830	USD
CY2013Q3	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	13384812	USD
	xxii	Warrants With Provision Of Anti Dilution WarrantsWithProvisionOfAntiDilution	129809	shares
	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	52500	USD
	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	528080	USD
CY2013Q3	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	52500	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	20550	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	250285	USD
CY2013Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	20550	USD
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	59413	USD
	us-gaap	Gross Profit GrossProfit	31950	USD
	us-gaap	Gross Profit GrossProfit	31361	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	31950	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	-241416	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	498746	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	835050	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	142912	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	349335	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3456642	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4160775	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	907993	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1810908	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	0	USD
CY2013Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	0	USD
CY2014Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	269399	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4332	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	57575	USD
CY2013Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4332	USD
CY2014Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	23415	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	173118	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	325962	USD
CY2013Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	63518	USD
CY2014Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	130349	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4132838	USD
	us-gaap	Costs And Expenses CostsAndExpenses	6081528	USD
CY2013Q3	us-gaap	Costs And Expenses CostsAndExpenses	1118755	USD
CY2014Q3	us-gaap	Costs And Expenses CostsAndExpenses	2583406	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4100888	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6050167	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1086805	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2824822	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-13485564	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-3850295	USD
CY2013Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-13727891	USD
	xxii	Warrant Exchange Inducement Expense WarrantExchangeInducementExpense	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	71121	USD
CY2013Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2014Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-14500	USD
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	17827	USD
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	0	USD
CY2013Q3	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	5672	USD
CY2014Q3	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	0	USD
	us-gaap	Interest Expense Other InterestExpenseOther	727396	USD
	us-gaap	Interest Expense Other InterestExpenseOther	5306	USD
CY2013Q3	us-gaap	Interest Expense Other InterestExpenseOther	552149	USD
CY2014Q3	us-gaap	Interest Expense Other InterestExpenseOther	1788	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14230787	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3955085	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14285712	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	100513	USD
	us-gaap	Net Income Loss NetIncomeLoss	-18331675	USD
	us-gaap	Net Income Loss NetIncomeLoss	-10005252	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-15372517	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-2724309	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.44
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	60103693	shares
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.32
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41203732	shares
	xxii	Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants	-204513	USD
	xxii	Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants	-6542904	USD
CY2013	xxii	Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants	-7712170	USD
CY2013	xxii	Reclassification Of Warrant Liability To Equity Resulting From Warrant Exchange Program ReclassificationOfWarrantLiabilityToEquityResultingFromWarrantExchangeProgram	-19639465	USD
CY2014Q1	xxii	Reclassification Of Derivative Liability To Equity Due To Warrant Amendments ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments	-7367915	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58687238	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47389538	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60103693	shares
CY2014Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	13674409	USD
CY2013Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	6022319	USD
CY2013Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	711675	USD
CY2013Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1622069	USD
CY2012Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4173140	USD
CY2013	xxii	Warrant Exchange Inducement Expense WarrantExchangeInducementExpense	3274313	USD
CY2014Q1	xxii	Warrant Exchange Inducement Expense WarrantExchangeInducementExpense	144548	USD
CY2013	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	19271977	USD
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	12972664	shares
CY2013Q4	xxii	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	11570274	shares
CY2013	xxii	Class Of Warrants Or Rights Issued Under Warrant Exchange Program ClassOfWarrantsOrRightsIssuedUnderWarrantExchangeProgram	138666	shares
	xxii	Common Stock Warrants Issued Additional Number CommonStockWarrantsIssuedAdditionalNumber	18383	shares
CY2013	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	-9831414	shares
	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	-1247443	shares
CY2013	xxii	Number Of Warrants Exercised Under Warrant Exchange Program NumberOfWarrantsExercisedUnderWarrantExchangeProgram	5862121	shares
CY2013Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10653469	shares
CY2014Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13674409	shares
CY2014Q3	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	96000	USD
CY2014Q3	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	123000	USD
CY2014Q3	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	298275	USD
CY2014Q3	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	338250	USD
CY2014Q3	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	338250	USD
	xxii	Research And Development Arrangement Contract Terms ResearchAndDevelopmentArrangementContractTerms	two-year term
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41203732	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	58687238	shares
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	47389538	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20796308	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14814409	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1313201	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	122486	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	288750	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	122486	shares
CY2014Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1334000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.68
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.07
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	186959	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	103250	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	48300	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	70000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	215000	shares
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0189	pure
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0180	pure
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.9	pure
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.9	pure
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P10Y
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P10Y
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	465000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	215000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	300000	shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	20000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	660000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	890000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	640000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.69
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.80
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.61
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.26
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.69
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.74
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.38
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.89
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1046200	USD
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1046200	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1749886	USD
	xxii	Stock Issued During Period Warrants Excercised Value StockIssuedDuringPeriodWarrantsExcercisedValue	486951	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	48300	USD
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	25200	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	7367915	USD
	us-gaap	Profit Loss ProfitLoss	-10005252	USD
	us-gaap	Profit Loss ProfitLoss	-18331675	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	173118	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	325962	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4232	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	134296	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	71121	USD
	xxii	Non Cash Interest On Convertible Debt NonCashInterestOnConvertibleDebt	526448	USD
	xxii	Non Cash Interest On Convertible Debt NonCashInterestOnConvertibleDebt	0	USD
	xxii	Warrant Liability Loss WarrantLiabilityLoss	-13485564	USD
	xxii	Warrant Liability Loss WarrantLiabilityLoss	-3850295	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	946321	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1609716	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1313201	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	162656	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	57683	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	304100	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	12679	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	175023	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-297879	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	378828	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	11844	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-317810	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	433318	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-179014	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2422702	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3795112	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	70211	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	460092	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	22453	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	543735	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	339250	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	175641	USD
	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	0	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	700000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-92664	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1879249	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2254999	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	486951	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	150000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	1660	USD
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	0	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	3500	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2500	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3893	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	7471	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3550945	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	9864310	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1035579	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4189949	USD
CY2012Q4	us-gaap	Cash Cash	188	USD
CY2013Q3	us-gaap	Cash Cash	1035767	USD
	us-gaap	Interest Paid Net InterestPaidNet	79015	USD
	us-gaap	Interest Paid Net InterestPaidNet	5325	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	xxii	Reclassification Of Derivative Liability To Equity Due To Warrant Amendments ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments	5849500	USD
	xxii	Reclassification Of Derivative Liability To Equity Due To Warrant Amendments ReclassificationOfDerivativeLiabilityToEquityDueToWarrantAmendments	7367915	USD
	xxii	Patent And Trademark Additions Included In Accounts Payable PatentAndTrademarkAdditionsIncludedInAccountsPayable	166521	USD
	xxii	Patent And Trademark Additions Included In Accounts Payable PatentAndTrademarkAdditionsIncludedInAccountsPayable	52808	USD
	xxii	Reclassification Of Machinery And Equipment Purchases To Inventory ReclassificationOfMachineryAndEquipmentPurchasesToInventory	0	USD
	xxii	Reclassification Of Machinery And Equipment Purchases To Inventory ReclassificationOfMachineryAndEquipmentPurchasesToInventory	37856	USD
	xxii	Other Contributed Capital OtherContributedCapital	0	USD
	xxii	Other Contributed Capital OtherContributedCapital	25200	USD
	xxii	Conversion Of Accounts Payable To Note Payable ConversionOfAccountsPayableToNotePayable	769377	USD
	xxii	Conversion Of Accounts Payable To Note Payable ConversionOfAccountsPayableToNotePayable	0	USD
	xxii	Conversion Of Accrued Interest To Note Payable ConversionOfAccruedInterestToNotePayable	26422	USD
	xxii	Conversion Of Accrued Interest To Note Payable ConversionOfAccruedInterestToNotePayable	0	USD
	xxii	Conversion Of Notes Payable And Accrued Interest To Common Stock ConversionOfNotesPayableAndAccruedInterestToCommonStock	1650305	USD
	xxii	Conversion Of Notes Payable And Accrued Interest To Common Stock ConversionOfNotesPayableAndAccruedInterestToCommonStock	0	USD
	xxii	Dividend Payable On Preferred Stock DividendPayableOnPreferredStock	93361	USD
	xxii	Dividend Payable On Preferred Stock DividendPayableOnPreferredStock	0	USD
	xxii	Issuance Of Common Stock Value In Payment Of Financing Cost IssuanceOfCommonStockValueInPaymentOfFinancingCost	416666	USD
	xxii	Issuance Of Common Stock Value In Payment Of Financing Cost IssuanceOfCommonStockValueInPaymentOfFinancingCost	0	USD
	xxii	Refinance Of Note Payable To Accounts Payable RefinanceOfNotePayableToAccountsPayable	57500	USD
	xxii	Refinance Of Note Payable To Accounts Payable RefinanceOfNotePayableToAccountsPayable	0	USD
	xxii	Issuance Of Warrants As Derivative Liability Instrument IssuanceOfWarrantsAsDerivativeLiabilityInstrument	5675634	USD
	xxii	Issuance Of Warrants As Derivative Liability Instrument IssuanceOfWarrantsAsDerivativeLiabilityInstrument	0	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	250000	USD
CY2014Q3	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.2	pure
CY2014Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5528053	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1544869	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	170946	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5528053	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1544869	USD
CY2014Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4047514	USD
CY2013Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	0	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	22nd Century Group, Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001347858
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	XXII
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	64325042	shares
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	USD
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-26057	USD
CY2013Q3	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	USD
CY2014Q3	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-26057	USD
	xxii	Warrants Issued In Conjunction With Consulting Agreement WarrantsIssuedInConjunctionWithConsultingAgreement	4250000	shares
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1260000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9324088	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1952000	USD
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	394500	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	8018	USD
	us-gaap	Payments For Fees PaymentsForFees	0	USD
	us-gaap	Payments For Fees PaymentsForFees	925000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	181716	USD
CY2013Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62667	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	61638	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	105000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	4330734	USD
	xxii	License Fee Included In Accrued Expenses LicenseFeeIncludedInAccruedExpenses	0	USD
	xxii	License Fee Included In Accrued Expenses LicenseFeeIncludedInAccruedExpenses	525000	USD
	xxii	Equity Investment Included In Accrued Expenses EquityInvestmentIncludedInAccruedExpenses	0	USD
	xxii	Equity Investment Included In Accrued Expenses EquityInvestmentIncludedInAccruedExpenses	325000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	394500	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
	xxii	Issuance Of Derivative Liability Warrants Issued Under Consulting Agreement IssuanceOfDerivativeLiabilityWarrantsIssuedUnderConsultingAgreement	0	USD
	xxii	Issuance Of Derivative Liability Warrants Issued Under Consulting Agreement IssuanceOfDerivativeLiabilityWarrantsIssuedUnderConsultingAgreement	2810000	USD
	xxii	Increase Warrant Liability Adjustments IncreaseWarrantLiabilityAdjustments	626328	USD
	xxii	Increase Warrant Liability Adjustments IncreaseWarrantLiabilityAdjustments	0	USD
	xxii	Issuance Of Derivative Liability Limited Market Makegood Provision IssuanceOfDerivativeLiabilityLimitedMarketMakegoodProvision	290000	USD
	xxii	Issuance Of Derivative Liability Limited Market Makegood Provision IssuanceOfDerivativeLiabilityLimitedMarketMakegoodProvision	0	USD
	xxii	Warrants Issued Under Consulting Agreement Resulting In Capital WarrantsIssuedUnderConsultingAgreementResultingInCapital	0	USD
	xxii	Warrants Issued Under Consulting Agreement Resulting In Capital WarrantsIssuedUnderConsultingAgreementResultingInCapital	1260000	USD
	xxii	Warrants Exchange Rights WarrantsExchangeRights	1250000	shares
CY2014Q3	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	8018	USD
	xxii	Lease Payments LeasePayments	3605	USD
CY2014Q3	us-gaap	Goodwill Goodwill	852000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	0	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	852000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent		USD
CY2013Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	85621	USD
	us-gaap	License Costs LicenseCosts	0	USD
	us-gaap	License Costs LicenseCosts	246434	USD
CY2013Q3	us-gaap	License Costs LicenseCosts	0	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20550	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	496719	USD
CY2013Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20550	USD
CY2014Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	305847	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	852000	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	852000	USD

Files In Submission

Name	View Source	Status
0001144204-14-068255-index-headers.html	Edgar Link	pending
0001144204-14-068255-index.html	Edgar Link	pending
0001144204-14-068255.txt	Edgar Link	pending
0001144204-14-068255-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v392788_10q.htm	Edgar Link	pending
v392788_31-1.htm	Edgar Link	pending
v392788_31-2.htm	Edgar Link	pending
v392788_32-1.htm	Edgar Link	pending
xxii-20140930.xml	Edgar Link	completed
xxii-20140930.xsd	Edgar Link	pending
xxii-20140930_cal.xml	Edgar Link	unprocessable
xxii-20140930_def.xml	Edgar Link	unprocessable
xxii-20140930_lab.xml	Edgar Link	unprocessable
xxii-20140930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XXII
22nd Century Group, Inc. Stock $xxii

2014 Q4 Form 10-Q Financial Statement

#000114420414068255 Filed on November 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII 22nd Century Group, Inc. Stock $xxii

2014 Q4 Form 10-Q Financial Statement

#000114420414068255 Filed on November 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII
22nd Century Group, Inc. Stock $xxii